Navigation Links
Lilly and the William Sansum Diabetes Center announce a five-year research collaboration

SANTA BARBARA, Calif. and INDIANAPOLIS, March 23, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care.

"The tremendous burden of diabetes and cardiovascular disease bears a disproportionate weight on Latino families in the United States," said David Kerr, M.D., FRCPE, director of Innovation and Research for the William Sansum Diabetes Center. "This collaboration with Lilly will allow us to gain a better understanding of how we can help these families."

Dr. Kerr added that Latino people comprise 43% of the total population in Santa Barbara County, and rates of cardio-metabolic disease are persistently higher than in the rest of the population due to a combination of factors beyond biological risk, including economics, culture and education.

For Lilly, the collaboration will provide valuable insights into patients' unmet needs and aid in the development of interventions that could improve health outcomes for Latino people.

"This is a great opportunity for us to further understand the significant impact of diabetes for Latino families," said Dara Schuster, M.D., senior director of U.S. Medical Affairs for Lilly Diabetes. "Through this collaboration, we will learn where the gaps are so we can develop meaningful solutions for the unmet needs."

About William Sansum Diabetes Center The William Sansum Diabetes Center has been on the cutting edge of diabetes research, clinical care, and education since its founding in 1944 by Dr. William Sansum, the first U.S. physician to administer insulin in the treatment of diabetes. The Center has developed new technologies and produced groundbreaking diabetes treatments, such as the artificial pancreas automating delivery of insulin to patients and new protocols for the management of pregnancies complicated by diabetes. Today, the Center has international recognition for research and innovation in the creation, development, and application of novel and effective smart technologies. The Center is committed to developing effective approaches to the education of clinicians, people with diabetes and their families, and healthcare providers in partnership with academic institutions, specialist diabetes centers, and primary care colleagues. For more information, please visit

About Lilly Diabetes Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a wide range of therapies and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit or follow us on Twitter: @LillyDiabetes.

About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and

Refer to:

David Kerr, MD

Julie WilliamsWilliam Sansum Diabetes Center

Eli Lilly and (805) 682-7640 Ext. 241

(317) 627-4056

SOURCE Eli Lilly and Company
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly To Present At Leerink Partners Global Healthcare Conference
2. Lilly Revises Time for Conference Call for Fourth-Quarter 2016 Financial Results Announcement
3. Lilly Announces Dividend Increase
4. Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimers Disease (CTAD) 2016 Meeting
5. Diabetes Injection Pens Market is Expected to be Worth US$9.7 Billion by 2024 - Leading Players Operating are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A
6. Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer
7. Lilly Confirms Date and Conference Call for 2017 Financial Guidance Announcement
8. Drug Makers Stocks Under Scanner -- Eli Lilly, Provectus Biopharma, GlaxoSmithKline, and Novartis
9. Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
10. Global Diabetic Care Market to Reach $122 Billion by 2022 - Key Vendors are GlaxosmithKline, Abbott Laboratories & Eli Lilly And Company
11. Lilly to Participate in Barclays Global Healthcare Conference
Post Your Comments:
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
Breaking Medicine Technology:
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):